Discover
PLSE
Pulse Biosciences, Inc.
53.81
2 x 38.50
2 x 63.97
bid
ask
+
3.83
7.66%
2 @ 06:11 PM
53.00 -0.81 (1.51%)
| Ytd | 291.92% | |
| 1y | 179.53% |
50.23
day range
53.97
12.66
52 week range
55.20
| Open | 50.23 | Prev Close | 49.98 | Low | 50.23 | High | 53.97 | Mkt Cap | 3.84B |
| Vol | 367.60K | Avg Vol | 502.81K | EPS | -1.18 | P/E | N/A | Forward P/E | -45.99 |
| Beta | 1.57 | Short Ratio | 5.23 | Inst. Own | 15.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 48.22 | 200-d Avg | 28.43 | 1yr Est | 56.50 |
| Income Statement | |||
| Total Revenue | 434.00K | ||
| Revenues (USD) | 434.00K | ||
| Cost of Revenue | 273.00K | ||
| Gross Profit | 161.00K | ||
| Operating Expenses | 25.43M | ||
| Research and Development Expense | 16.98M | ||
| Selling, General and Administrative Expense | 8.46M | ||
| Operating Income | -25.27M | ||
| Net Income | -24.66M | ||
| Net Income Common Stock | -24.66M | ||
| Net Income Common Stock (USD) | -24.66M | ||
| Consolidated Income | -24.66M | ||
| Earnings per Basic Share | -0.36 | ||
| Earnings per Basic Share (USD) | -0.36 | ||
| Earnings per Diluted Share | -0.36 | ||
| Earning Before Interest & Taxes (EBIT) | -24.66M | ||
| Earning Before Interest & Taxes (USD) | -24.66M | ||
| Weighted Average Shares | 69.20M | ||
| Weighted Average Shares Diluted | 69.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 101.62M | ||
| Cash and Equivalents (USD) | 101.62M | ||
| Trade and Non-Trade Receivables | 122.00K | ||
| Current Assets | 105.70M | ||
| Property, Plant & Equipment Net | 6.45M | ||
| Total Assets | 115.56M | ||
| Debt Current | 1.69M | ||
| Total Debt | 6.77M | ||
| Current Liabilities | 10.98M | ||
| Debt Non-Current | 5.09M | ||
| Total Liabilities | 16.06M | ||
| Accumulated Retained Earnings (Deficit) | -506.52M | ||
| Shareholders Equity | 99.50M | ||
| Shareholders Equity (USD) | 99.50M | ||
| Assets Non-Current | 9.86M | ||
| Total Debt (USD) | 6.77M | ||
| Goodwill and Intangible Assets | 3.01M | ||
| Inventory | 236.00K | ||
| Liabilities Non-Current | 5.09M | ||
| Trade and Non-Trade Payables | 2.83M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 571.00K | ||
| Net Cash Flow from Financing | 52.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 33.30M | ||
| Capital Expenditure | -90.00K | ||
| Issuance (Purchase) of Equity Shares | 52.04M | ||
| Net Cash Flow from Investing | -90.00K | ||
| Net Cash Flow from Operations | -18.71M | ||
| Share Based Compensation | 4.97M | ||